Aastrom Biosciences has announced plans to initiate a world-first phase II trial of its Cardiac Repair Cells in congestive cardiomyopathy.

&NA;

doi:10.2165/00128413-200816440-00020

Aastrom Biosciences has announced plans to initiate a world-first phase II trial of its Cardiac Repair Cells in congestive cardiomyopathy.

Inpharma Weekly ◽

10.2165/00128413-200816440-00020 ◽

2008 ◽

Vol &NA; (1644) ◽

pp. 10

Author(s):

&NA;

Keyword(s):

Phase Ii ◽

Phase Ii Trial ◽

Cardiac Repair ◽

Congestive Cardiomyopathy

Download Full-text

1400: A Randomized Phase II Trial Evaluating the Importance of Early Erectile Dysfunction Rehabilitation and Unilateral Autologous Sural Nerve Grafting in Patients Undergoing a Unilateral Cavernous Nerve Sparing Radical Prostatectomy for Clinically localized PR

The Journal of Urology ◽

10.1016/s0022-5347(18)31601-x ◽

2007 ◽

Vol 177 (4S) ◽

pp. 461-461 ◽

Cited By ~ 1

Author(s):

Christopher G. Wood ◽

David Chang ◽

Run Wang ◽

Yu Shen ◽

Curtis A. Pettaway ◽

...

Keyword(s):

Erectile Dysfunction ◽

Radical Prostatectomy ◽

Phase Ii ◽

Sural Nerve ◽

Phase Ii Trial ◽

Nerve Sparing ◽

Nerve Grafting ◽

Cavernous Nerve ◽

Randomized Phase Ii

Download Full-text

1326: Phase II Trial of Gemcitabine, Paclitaxel, and Cisplatin in Advanced Transitional Cell Carcinoma

The Journal of Urology ◽

10.1016/s0022-5347(18)35471-5 ◽

2005 ◽

Vol 173 (4S) ◽

pp. 360-360

Author(s):

Peter E. Clark ◽

Diana Stindt ◽

M. Craig Hall ◽

Michele Harmon ◽

James F. Lovato ◽

...

Keyword(s):

Transitional Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Phase Ii Trial ◽

Transitional Cell

Download Full-text

Experimental Drug Shows Activity Against Advanced Ovarian Cancer in Phase II Trial

Ob Gyn News ◽

10.1016/s0029-7437(07)70576-1 ◽

2007 ◽

Vol 42 (13) ◽

pp. 2

Author(s):

PATRICE WENDLING

Keyword(s):

Ovarian Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Advanced Ovarian Cancer ◽

Experimental Drug

Download Full-text

Phase II trial of weekly paclitaxel (80 mg/m2) in platinum and paclitaxel-resistant ovarian and primary peritoneal cancers: A Gynecologic Oncology Group study

Yearbook of Oncology ◽

10.1016/s1040-1741(08)70331-2 ◽

2007 ◽

Vol 2007 ◽

pp. 82-83

Author(s):

J.T. Thigpen

Keyword(s):

Phase Ii ◽

Phase Ii Trial ◽

Gynecologic Oncology ◽

Weekly Paclitaxel ◽

Gynecologic Oncology Group ◽

Oncology Group ◽

Oncology Group Study

Download Full-text

Axitinib Shrinks Thyroid Cancer in Phase II Trial

Internal Medicine News ◽

10.1016/s1097-8690(07)70861-2 ◽

2007 ◽

Vol 40 (14) ◽

pp. 22

Author(s):

JANE SALODOF MACNEIL

Keyword(s):

Thyroid Cancer ◽

Phase Ii ◽

Phase Ii Trial

Download Full-text

Phase II Trial of Thalidomide, Irinotecan and Gemcitabine in Chemonaive Patients with Advanced Non-Small Cell Lung Cancer

Cancer Investigation ◽

10.1080/07357900801944856 ◽

2009 ◽

pp. 1-1

Author(s):

A. R. Jazieh ◽

R. Komrokji ◽

A. Gupta ◽

S. Patil ◽

D. Flora ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell ◽

Small Cell Lung

Download Full-text

Author response for "A phase II trial of bendamustine in combination with ofatumumab in patients with relapsed or refractory marginal zone B‐cell lymphomas"

10.1002/hon.2822/v2/response1 ◽

2020 ◽

Author(s):

Barbara Vannata ◽

Anna Vanazzi ◽

Mara Negri ◽

Sarah Jayne Liptrott ◽

Anna Amalia Bartosek ◽

...

Keyword(s):

B Cell ◽

Phase Ii ◽

Marginal Zone ◽

Phase Ii Trial ◽

Author Response ◽

B Cell Lymphomas

Download Full-text

Review for "A phase II trial of bendamustine in combination with ofatumumab in patients with relapsed or refractory marginal zone B‐cell lymphomas"

10.1002/hon.2822/v1/review2 ◽

2020 ◽

Keyword(s):

B Cell ◽

Phase Ii ◽

Marginal Zone ◽

Phase Ii Trial ◽

B Cell Lymphomas

Download Full-text

Phase II trial of single-agent weekly docetaxel in hormone-refractory, symptomatic, metastatic carcinoma of the prostate

Seminars in Oncology ◽

10.1053/sonc.2001.26893 ◽

2001 ◽

Vol 28 (4M) ◽

pp. 8-15 ◽

Cited By ~ 10

Author(s):

William Berry ◽

Shaker Dakhil ◽

Mary A. Gregurich ◽

Lina Asmar

Keyword(s):

Phase Ii ◽

Phase Ii Trial ◽

Single Agent ◽

Metastatic Carcinoma ◽

Carcinoma Of The Prostate ◽

Weekly Docetaxel ◽

Hormone Refractory

Download Full-text

An open-label, multicenter phase II trial of SUNITINIB for patients with chemorefractory metastatic gastric cancer

Zeitschrift für Gastroenterologie ◽

10.1055/s-0030-1263569 ◽

2010 ◽

Vol 48 (08) ◽

Cited By ~ 1

Author(s):

M Moehler ◽

J Hartmann ◽

F Lordick ◽

S Al-Batran ◽

P Reimer ◽

...

Keyword(s):

Gastric Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Gastric Cancer ◽

Open Label ◽

Multicenter Phase

Download Full-text